Published in Scand J Infect Dis on January 01, 1994
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther (2010) 1.99
Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS (2013) 1.71
HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) (2013) 0.93
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection. J Neuroinflammation (2014) 0.91
A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy. Infect Dis Obstet Gynecol (1999) 0.86
Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infect Dis (2006) 0.83
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. J Neuroimmunol (2016) 0.76
Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm (2016) 0.75
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet (1998) 14.31
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol (1988) 4.96
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (1982) 3.50
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med (1984) 3.31
Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today (1988) 3.13
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis (1999) 2.75
Antibody response in primary human immunodeficiency virus infection. Lancet (1987) 2.69
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46
Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem (1997) 2.39
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS (2001) 2.28
Neopterin as a marker for immune system activation. Curr Drug Metab (2002) 2.25
Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine]. J Gen Virol (1986) 2.24
Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol (1984) 2.22
Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp (1981) 2.15
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol (2000) 2.11
Herpes simplex virus infection of the human sensory neuron. An electron microscopy study. Arch Virol (1988) 2.08
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Infection of brain-derived cells with the human immunodeficiency virus. J Virol (1987) 2.01
Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett (1991) 1.96
Epidemiological aspects of Campylobacter jejuni enteritis. J Hyg (Lond) (1982) 1.95
Immune activation and psoriasis. Lancet (1991) 1.93
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
Campylobacter jejuni enteritis transmitted from cat to man. Lancet (1980) 1.85
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med (1990) 1.81
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol (1995) 1.74
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods (1998) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology (1994) 1.71
Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes. J Gen Virol (1979) 1.70
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol (2001) 1.67
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Clin Chem (1989) 1.66
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS (2001) 1.63
Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol (1987) 1.61
Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J (1993) 1.61
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol (1998) 1.61
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem (1989) 1.59
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology (2002) 1.56
Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med (1994) 1.55
Differences in attachment between herpes simplex type 1 and type 2 viruses to neurons and glial cells. Infect Immun (1980) 1.53
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr (1999) 1.53
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol (1995) 1.51
An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med (2000) 1.51
Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49
Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol (1984) 1.48
Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies. J Clin Microbiol (1999) 1.48
Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Transplantation (1983) 1.47
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods (1994) 1.46
Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun (1987) 1.45
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer (2002) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci (1992) 1.42
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1. Oncogene (2006) 1.42
Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci (1987) 1.42
Bacterial adherence--a pathogenetic mechanism in urinary tract infections caused by Escherichia coli. Prog Allergy (1983) 1.42
Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother (2001) 1.42
[Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)]. Hoppe Seylers Z Physiol Chem (1979) 1.41
Reducing HIV transmission by seronegative blood. Lancet (1992) 1.41
Evaluation of the adaptive learning environments model. Except Child (1988) 1.40
Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr (1990) 1.39
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. AIDS (1997) 1.39
Altered iron metabolism and the anemia of chronic disease: a role of immune activation. Blood (1992) 1.39
Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol (1998) 1.37
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol (1993) 1.36
Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem (1993) 1.35
Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol (1994) 1.35
Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol (1983) 1.34
Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc Natl Acad Sci U S A (1991) 1.34